Source link : https://newshealth.biz/health-news/novel-drug-for-her2-mutant-lung-cancer-wins-fda-approval/
(MedPage Today) — The FDA on Friday granted accelerated approval to zongertinib (Hernexeos) for non-squamous non-small cell lung cancer (NSCLC) patients harboring HER2 tyrosine kinase domain (TKD) activating mutations. Approval of the tyrosine… Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/116921 Author : Publish date : 2025-08-08 21:19:00 Copyright for syndicated content belongs to the linked Source.
The post Novel Drug for HER2-Mutant Lung Cancer Wins FDA Approval first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-08 21:19:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8